David Rescott

Stock Analyst at Baird

(3.57)
# 797
Out of 5,169 analysts
81
Total ratings
56.45%
Success rate
4.2%
Average return

Stocks Rated by David Rescott

PROCEPT BioRobotics
Mar 6, 2026
Initiates: Neutral
Price Target: $30
Current: $27.36
Upside: +9.65%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103$100
Current: $88.44
Upside: +13.07%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $118$101
Current: $71.20
Upside: +41.85%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345$374
Current: $338.00
Upside: +10.65%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21$23
Current: $12.84
Upside: +79.13%
Edwards Lifesciences
Dec 16, 2025
Maintains: Neutral
Price Target: $88$87
Current: $84.27
Upside: +3.24%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87$99
Current: $60.05
Upside: +64.86%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63$70
Current: $62.43
Upside: +12.13%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $70.23
Upside: +56.63%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $482.76
Upside: +19.11%